Taysha Gene Therapies Funding: $125M Raised, Series B (2020)
Taysha Gene Therapies is based in Dallas, TX. It has raised $125M in total funding. Latest round: Series B. Backed by Fidelity, PBM Capital.
Taysha Gene Therapies funding overview
Taysha Gene Therapies is based in Dallas, TX. Taysha Gene Therapies has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in August 2020. The round record for Taysha Gene Therapies runs through 2020; nothing later has been disclosed. Investors on record include Fidelity, PBM Capital. 2 distinct backers are named across the disclosed rounds.
Taysha Gene Therapies at a glance
Total raised
$125M
Latest round
Series B
Latest round date
August 2020
Headquarters
Dallas, TX
Notable investors
Fidelity, PBM Capital
Frequently asked about Taysha Gene Therapies funding
How much has Taysha Gene Therapies raised?
Taysha Gene Therapies has raised $125M in total disclosed funding across the rounds on record.
Who has invested in Taysha Gene Therapies?
Fidelity, PBM Capital are named among the investors backing Taysha Gene Therapies.
What was the latest Taysha Gene Therapies funding round?
The most recent disclosed round is a Series B, announced in August 2020.
Where is Taysha Gene Therapies based?
Taysha Gene Therapies is based in Dallas, TX.
When did Taysha Gene Therapies last raise?
The last disclosed Taysha Gene Therapies round closed in August 2020 at Series B.
Totals shown for Taysha Gene Therapies aggregate every disclosed round on file. To see how that compares, browse the companies in Dallas and the investors behind them below.
